학술논문
Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation
Document Type
Article
Source
In: Journal of Allergy and Clinical Immunology . (Journal of Allergy and Clinical Immunology, 1 February 2015, 135(2):551-553.e3)
Subject
Language
English
ISSN
10976825
00916749
00916749